Division of Medicine,
Brighton and Sussex Medical School,
UK
In 1995, at the age of 30, Martin Fisher was appointed a consultant in HIV and genitourinary medicine in Brighton. He had qualified just seven years earlier, and then trained in genitourinary and HIV medicine, initially under Brian Gazzard at the Westminster Hospital and later at St Mary’s Hospital in Paddington.
Martin could not have arrived in Brighton at a more propitious time. The world of HIV medicine was tilting on its axis. The results of the DELTA and ACTG 175 studies had just been released, showing for the first time that the combination of two antiretroviral drugs could prolong life significantly in HIV positive people.1 Just months later, at the 1996 World AIDS Conference in Vancouver, numerous studies showed that combinations of three drugs were even more potent, and HIV changed from being universally fatal into a treatable condition.
HIV
Journal of AIDS & Clinical Research received 5061 citations as per Google Scholar report